N-(4-carbazol-9-ylphenyl)-4-[3-[4-(N-(4-carbazol-9-ylphenyl)anilino)phenyl]-5-methylpyrazin-2-yl]-N-phenylaniline;N-[4-(3,6-dimethylcarbazol-9-yl)phenyl]-4-[3-[4-(N-[4-(3,6-dimethylcarbazol-9-yl)phenyl]anilino)phenyl]-5,6-diphenylpyrazin-2-yl]-N-phenylaniline;N-[4-(3,6-diphenylcarbazol-9-yl)phenyl]-4-[3-[4-(N-[4-(3,6-diphenylcarbazol-9-yl)phenyl]anilino)phenyl]pyrazin-2-yl]-N-phenylaniline

C233H166N18 — CID 157059441

IUPACN-(4-carbazol-9-ylphenyl)-4-[3-[4-(N-(4-carbazol-9-ylphenyl)anilino)phenyl]-5-methylpyrazin-2-yl]-N-phenylaniline;N-[4-(3,6-dimethylcarbazol-9-yl)phenyl]-4-[3-[4-(N-[4-(3,6-dimethylcarbazol-9-yl)phenyl]anilino)phenyl]-5,6-diphenylpyrazin-2-yl]-N-phenylaniline;N-[4-(3,6-diphenylcarbazol-9-yl)phenyl]-4-[3-[4-(N-[4-(3,6-diphenylcarbazol-9-yl)phenyl]anilino)phenyl]pyrazin-2-yl]-N-phenylaniline
SMILESCc1ccc2c(c1)c1cc(C)ccc1n2-c1ccc(N(c2ccccc2)c2ccc(-c3nc(-c4ccccc4)c(-c4ccccc4)nc3-c3ccc(N(c4ccccc4)c4ccc(-n5c6ccc(C)cc6c6cc(C)ccc65)cc4)cc3)cc2)cc1.Cc1cnc(-c2ccc(N(c3ccccc3)c3ccc(-n4c5ccccc5c5ccccc54)cc3)cc2)c(-c2ccc(N(c3ccccc3)c3ccc(-n4c5ccccc5c5ccccc54)cc3)cc2)n1.c1ccc(-c2ccc3c(c2)c2cc(-c4ccccc4)ccc2n3-c2ccc(N(c3ccccc3)c3ccc(-c4nccnc4-c4ccc(N(c5ccccc5)c5ccc(-n6c7ccc(-c8ccccc8)cc7c7cc(-c8ccccc8)ccc76)cc5)cc4)cc3)cc2)cc1
InChIInChI=1S/C88H60N6.C80H60N6.C65H46N6/c1-7-19-61(20-8-1)67-35-51-83-79(57-67)80-58-68(62-21-9-2-10-22-62)36-52-84(80)93(83)77-47-43-75(44-48-77)91(71-27-15-5-16-28-71)73-39-31-65(32-40-73)87-88(90-56-55-89-87)66-33-41-74(42-34-66)92(72-29-17-6-18-30-72)76-45-49-78(50-46-76)94-85-53-37-69(63-23-11-3-12-24-63)59-81(85)82-60-70(38-54-86(82)94)64-25-13-4-14-26-64;1-53-25-45-73-69(49-53)70-50-54(2)26-46-74(70)85(73)67-41-37-65(38-42-67)83(61-21-13-7-14-22-61)63-33-29-59(30-34-63)79-80(82-78(58-19-11-6-12-20-58)77(81-79)57-17-9-5-10-18-57)60-31-35-64(36-32-60)84(62-23-15-8-16-24-62)66-39-43-68(44-40-66)86-75-47-27-55(3)51-71(75)72-52-56(4)28-48-76(72)86;1-45-44-66-64(46-28-32-50(33-29-46)68(48-16-4-2-5-17-48)52-36-40-54(41-37-52)70-60-24-12-8-20-56(60)57-21-9-13-25-61(57)70)65(67-45)47-30-34-51(35-31-47)69(49-18-6-3-7-19-49)53-38-42-55(43-39-53)71-62-26-14-10-22-58(62)59-23-11-15-27-63(59)71/h1-60H;5-52H,1-4H3;2-44H,1H3
InChIKeyABDPQFRCKPVBTF-UHFFFAOYSA-N
MW3218.02 g/mol
LogP62.38
Rot. Bonds36

About N-(4-carbazol-9-ylphenyl)-4-[3-[4-(N-(4-carbazol-9-ylphenyl)anilino)phenyl]-5-methylpyrazin-2-yl]-N-phenylaniline;N-[4-(3,6-dimethylcarbazol-9-yl)phenyl]-4-[3-[4-(N-[4-(3,6-dimethylcarbazol-9-yl)phenyl]anilino)phenyl]-5,6-diphenylpyrazin-2-yl]-N-phenylaniline;N-[4-(3,6-diphenylcarbazol-9-yl)phenyl]-4-[3-[4-(N-[4-(3,6-diphenylcarbazol-9-yl)phenyl]anilino)phenyl]pyrazin-2-yl]-N-phenylaniline

N-(4-carbazol-9-ylphenyl)-4-[3-[4-(N-(4-carbazol-9-ylphenyl)anilino)phenyl]-5-methylpyrazin-2-yl]-N-phenylaniline;N-[4-(3,6-dimethylcarbazol-9-yl)phenyl]-4-[3-[4-(N-[4-(3,6-dimethylcarbazol-9-yl)phenyl]anilino)phenyl]-5,6-diphenylpyrazin-2-yl]-N-phenylaniline;N-[4-(3,6-diphenylcarbazol-9-yl)phenyl]-4-[3-[4-(N-[4-(3,6-diphenylcarbazol-9-yl)phenyl]anilino)phenyl]pyrazin-2-yl]-N-phenylaniline (PubChem CID 157059441) has the molecular formula C233H166N18 and a molecular weight of 3218.02 g/mol. Its IUPAC name is N-(4-carbazol-9-ylphenyl)-4-[3-[4-(N-(4-carbazol-9-ylphenyl)anilino)phenyl]-5-methylpyrazin-2-yl]-N-phenylaniline;N-[4-(3,6-dimethylcarbazol-9-yl)phenyl]-4-[3-[4-(N-[4-(3,6-dimethylcarbazol-9-yl)phenyl]anilino)phenyl]-5,6-diphenylpyrazin-2-yl]-N-phenylaniline;N-[4-(3,6-diphenylcarbazol-9-yl)phenyl]-4-[3-[4-(N-[4-(3,6-diphenylcarbazol-9-yl)phenyl]anilino)phenyl]pyrazin-2-yl]-N-phenylaniline.

Molecular Properties

Compound NameN-(4-carbazol-9-ylphenyl)-4-[3-[4-(N-(4-carbazol-9-ylphenyl)anilino)phenyl]-5-methylpyrazin-2-yl]-N-phenylaniline;N-[4-(3,6-dimethylcarbazol-9-yl)phenyl]-4-[3-[4-(N-[4-(3,6-dimethylcarbazol-9-yl)phenyl]anilino)phenyl]-5,6-diphenylpyrazin-2-yl]-N-phenylaniline;N-[4-(3,6-diphenylcarbazol-9-yl)phenyl]-4-[3-[4-(N-[4-(3,6-diphenylcarbazol-9-yl)phenyl]anilino)phenyl]pyrazin-2-yl]-N-phenylaniline
PubChem CID157059441
Molecular FormulaC233H166N18
Molecular Weight3218.02 g/mol
Exact Mass3215.35
IUPAC NameN-(4-carbazol-9-ylphenyl)-4-[3-[4-(N-(4-carbazol-9-ylphenyl)anilino)phenyl]-5-methylpyrazin-2-yl]-N-phenylaniline;N-[4-(3,6-dimethylcarbazol-9-yl)phenyl]-4-[3-[4-(N-[4-(3,6-dimethylcarbazol-9-yl)phenyl]anilino)phenyl]-5,6-diphenylpyrazin-2-yl]-N-phenylaniline;N-[4-(3,6-diphenylcarbazol-9-yl)phenyl]-4-[3-[4-(N-[4-(3,6-diphenylcarbazol-9-yl)phenyl]anilino)phenyl]pyrazin-2-yl]-N-phenylaniline
SMILESCc1ccc2c(c1)c1cc(C)ccc1n2-c1ccc(N(c2ccccc2)c2ccc(-c3nc(-c4ccccc4)c(-c4ccccc4)nc3-c3ccc(N(c4ccccc4)c4ccc(-n5c6ccc(C)cc6c6cc(C)ccc65)cc4)cc3)cc2)cc1.Cc1cnc(-c2ccc(N(c3ccccc3)c3ccc(-n4c5ccccc5c5ccccc54)cc3)cc2)c(-c2ccc(N(c3ccccc3)c3ccc(-n4c5ccccc5c5ccccc54)cc3)cc2)n1.c1ccc(-c2ccc3c(c2)c2cc(-c4ccccc4)ccc2n3-c2ccc(N(c3ccccc3)c3ccc(-c4nccnc4-c4ccc(N(c5ccccc5)c5ccc(-n6c7ccc(-c8ccccc8)cc7c7cc(-c8ccccc8)ccc76)cc5)cc4)cc3)cc2)cc1
InChIInChI=1S/C88H60N6.C80H60N6.C65H46N6/c1-7-19-61(20-8-1)67-35-51-83-79(57-67)80-58-68(62-21-9-2-10-22-62)36-52-84(80)93(83)77-47-43-75(44-48-77)91(71-27-15-5-16-28-71)73-39-31-65(32-40-73)87-88(90-56-55-89-87)66-33-41-74(42-34-66)92(72-29-17-6-18-30-72)76-45-49-78(50-46-76)94-85-53-37-69(63-23-11-3-12-24-63)59-81(85)82-60-70(38-54-86(82)94)64-25-13-4-14-26-64;1-53-25-45-73-69(49-53)70-50-54(2)26-46-74(70)85(73)67-41-37-65(38-42-67)83(61-21-13-7-14-22-61)63-33-29-59(30-34-63)79-80(82-78(58-19-11-6-12-20-58)77(81-79)57-17-9-5-10-18-57)60-31-35-64(36-32-60)84(62-23-15-8-16-24-62)66-39-43-68(44-40-66)86-75-47-27-55(3)51-71(75)72-52-56(4)28-48-76(72)86;1-45-44-66-64(46-28-32-50(33-29-46)68(48-16-4-2-5-17-48)52-36-40-54(41-37-52)70-60-24-12-8-20-56(60)57-21-9-13-25-61(57)70)65(67-45)47-30-34-51(35-31-47)69(49-18-6-3-7-19-49)53-38-42-55(43-39-53)71-62-26-14-10-22-58(62)59-23-11-15-27-63(59)71/h1-60H;5-52H,1-4H3;2-44H,1H3
InChIKeyABDPQFRCKPVBTF-UHFFFAOYSA-N
XLogP62.38
TPSA126.36 Ų
H-Bond Donors
H-Bond Acceptors18
Rotatable Bonds36
Heavy Atoms251
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5003218.02
LogP ≤ 562.38
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1018

Analyze N-(4-carbazol-9-ylphenyl)-4-[3-[4-(N-(4-carbazol-9-ylphenyl)anilino)phenyl]-5-methylpyrazin-2-yl]-N-phenylaniline;N-[4-(3,6-dimethylcarbazol-9-yl)phenyl]-4-[3-[4-(N-[4-(3,6-dimethylcarbazol-9-yl)phenyl]anilino)phenyl]-5,6-diphenylpyrazin-2-yl]-N-phenylaniline;N-[4-(3,6-diphenylcarbazol-9-yl)phenyl]-4-[3-[4-(N-[4-(3,6-diphenylcarbazol-9-yl)phenyl]anilino)phenyl]pyrazin-2-yl]-N-phenylaniline with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-(4-carbazol-9-ylphenyl)-4-[3-[4-(N-(4-carbazol-9-ylphenyl)anilino)phenyl]-5-methylpyrazin-2-yl]-N-phenylaniline;N-[4-(3,6-dimethylcarbazol-9-yl)phenyl]-4-[3-[4-(N-[4-(3,6-dimethylcarbazol-9-yl)phenyl]anilino)phenyl]-5,6-diphenylpyrazin-2-yl]-N-phenylaniline;N-[4-(3,6-diphenylcarbazol-9-yl)phenyl]-4-[3-[4-(N-[4-(3,6-diphenylcarbazol-9-yl)phenyl]anilino)phenyl]pyrazin-2-yl]-N-phenylaniline?
The IUPAC name of N-(4-carbazol-9-ylphenyl)-4-[3-[4-(N-(4-carbazol-9-ylphenyl)anilino)phenyl]-5-methylpyrazin-2-yl]-N-phenylaniline;N-[4-(3,6-dimethylcarbazol-9-yl)phenyl]-4-[3-[4-(N-[4-(3,6-dimethylcarbazol-9-yl)phenyl]anilino)phenyl]-5,6-diphenylpyrazin-2-yl]-N-phenylaniline;N-[4-(3,6-diphenylcarbazol-9-yl)phenyl]-4-[3-[4-(N-[4-(3,6-diphenylcarbazol-9-yl)phenyl]anilino)phenyl]pyrazin-2-yl]-N-phenylaniline (CID 157059441) is N-(4-carbazol-9-ylphenyl)-4-[3-[4-(N-(4-carbazol-9-ylphenyl)anilino)phenyl]-5-methylpyrazin-2-yl]-N-phenylaniline;N-[4-(3,6-dimethylcarbazol-9-yl)phenyl]-4-[3-[4-(N-[4-(3,6-dimethylcarbazol-9-yl)phenyl]anilino)phenyl]-5,6-diphenylpyrazin-2-yl]-N-phenylaniline;N-[4-(3,6-diphenylcarbazol-9-yl)phenyl]-4-[3-[4-(N-[4-(3,6-diphenylcarbazol-9-yl)phenyl]anilino)phenyl]pyrazin-2-yl]-N-phenylaniline.
What is the SMILES notation for N-(4-carbazol-9-ylphenyl)-4-[3-[4-(N-(4-carbazol-9-ylphenyl)anilino)phenyl]-5-methylpyrazin-2-yl]-N-phenylaniline;N-[4-(3,6-dimethylcarbazol-9-yl)phenyl]-4-[3-[4-(N-[4-(3,6-dimethylcarbazol-9-yl)phenyl]anilino)phenyl]-5,6-diphenylpyrazin-2-yl]-N-phenylaniline;N-[4-(3,6-diphenylcarbazol-9-yl)phenyl]-4-[3-[4-(N-[4-(3,6-diphenylcarbazol-9-yl)phenyl]anilino)phenyl]pyrazin-2-yl]-N-phenylaniline?
The canonical SMILES for N-(4-carbazol-9-ylphenyl)-4-[3-[4-(N-(4-carbazol-9-ylphenyl)anilino)phenyl]-5-methylpyrazin-2-yl]-N-phenylaniline;N-[4-(3,6-dimethylcarbazol-9-yl)phenyl]-4-[3-[4-(N-[4-(3,6-dimethylcarbazol-9-yl)phenyl]anilino)phenyl]-5,6-diphenylpyrazin-2-yl]-N-phenylaniline;N-[4-(3,6-diphenylcarbazol-9-yl)phenyl]-4-[3-[4-(N-[4-(3,6-diphenylcarbazol-9-yl)phenyl]anilino)phenyl]pyrazin-2-yl]-N-phenylaniline is Cc1ccc2c(c1)c1cc(C)ccc1n2-c1ccc(N(c2ccccc2)c2ccc(-c3nc(-c4ccccc4)c(-c4ccccc4)nc3-c3ccc(N(c4ccccc4)c4ccc(-n5c6ccc(C)cc6c6cc(C)ccc65)cc4)cc3)cc2)cc1.Cc1cnc(-c2ccc(N(c3ccccc3)c3ccc(-n4c5ccccc5c5ccccc54)cc3)cc2)c(-c2ccc(N(c3ccccc3)c3ccc(-n4c5ccccc5c5ccccc54)cc3)cc2)n1.c1ccc(-c2ccc3c(c2)c2cc(-c4ccccc4)ccc2n3-c2ccc(N(c3ccccc3)c3ccc(-c4nccnc4-c4ccc(N(c5ccccc5)c5ccc(-n6c7ccc(-c8ccccc8)cc7c7cc(-c8ccccc8)ccc76)cc5)cc4)cc3)cc2)cc1.
What is the InChIKey of N-(4-carbazol-9-ylphenyl)-4-[3-[4-(N-(4-carbazol-9-ylphenyl)anilino)phenyl]-5-methylpyrazin-2-yl]-N-phenylaniline;N-[4-(3,6-dimethylcarbazol-9-yl)phenyl]-4-[3-[4-(N-[4-(3,6-dimethylcarbazol-9-yl)phenyl]anilino)phenyl]-5,6-diphenylpyrazin-2-yl]-N-phenylaniline;N-[4-(3,6-diphenylcarbazol-9-yl)phenyl]-4-[3-[4-(N-[4-(3,6-diphenylcarbazol-9-yl)phenyl]anilino)phenyl]pyrazin-2-yl]-N-phenylaniline?
The InChIKey is ABDPQFRCKPVBTF-UHFFFAOYSA-N. The full InChI is InChI=1S/C88H60N6.C80H60N6.C65H46N6/c1-7-19-61(20-8-1)67-35-51-83-79(57-67)80-58-68(62-21-9-2-10-22-62)36-52-84(80)93(83)77-47-43-75(44-48-77)91(71-27-15-5-16-28-71)73-39-31-65(32-40-73)87-88(90-56-55-89-87)66-33-41-74(42-34-66)92(72-29-17-6-18-30-72)76-45-49-78(50-46-76)94-85-53-37-69(63-23-11-3-12-24-63)59-81(85)82-60-70(38-54-86(82)94)64-25-13-4-14-26-64;1-53-25-45-73-69(49-53)70-50-54(2)26-46-74(70)85(73)67-41-37-65(38-42-67)83(61-21-13-7-14-22-61)63-33-29-59(30-34-63)79-80(82-78(58-19-11-6-12-20-58)77(81-79)57-17-9-5-10-18-57)60-31-35-64(36-32-60)84(62-23-15-8-16-24-62)66-39-43-68(44-40-66)86-75-47-27-55(3)51-71(75)72-52-56(4)28-48-76(72)86;1-45-44-66-64(46-28-32-50(33-29-46)68(48-16-4-2-5-17-48)52-36-40-54(41-37-52)70-60-24-12-8-20-56(60)57-21-9-13-25-61(57)70)65(67-45)47-30-34-51(35-31-47)69(49-18-6-3-7-19-49)53-38-42-55(43-39-53)71-62-26-14-10-22-58(62)59-23-11-15-27-63(59)71/h1-60H;5-52H,1-4H3;2-44H,1H3.
What are the key properties of N-(4-carbazol-9-ylphenyl)-4-[3-[4-(N-(4-carbazol-9-ylphenyl)anilino)phenyl]-5-methylpyrazin-2-yl]-N-phenylaniline;N-[4-(3,6-dimethylcarbazol-9-yl)phenyl]-4-[3-[4-(N-[4-(3,6-dimethylcarbazol-9-yl)phenyl]anilino)phenyl]-5,6-diphenylpyrazin-2-yl]-N-phenylaniline;N-[4-(3,6-diphenylcarbazol-9-yl)phenyl]-4-[3-[4-(N-[4-(3,6-diphenylcarbazol-9-yl)phenyl]anilino)phenyl]pyrazin-2-yl]-N-phenylaniline?
N-(4-carbazol-9-ylphenyl)-4-[3-[4-(N-(4-carbazol-9-ylphenyl)anilino)phenyl]-5-methylpyrazin-2-yl]-N-phenylaniline;N-[4-(3,6-dimethylcarbazol-9-yl)phenyl]-4-[3-[4-(N-[4-(3,6-dimethylcarbazol-9-yl)phenyl]anilino)phenyl]-5,6-diphenylpyrazin-2-yl]-N-phenylaniline;N-[4-(3,6-diphenylcarbazol-9-yl)phenyl]-4-[3-[4-(N-[4-(3,6-diphenylcarbazol-9-yl)phenyl]anilino)phenyl]pyrazin-2-yl]-N-phenylaniline has a molecular weight of 3218.02 g/mol, XLogP of 62.38, 36 rotatable bonds, 0 hydrogen bond donors, and 18 hydrogen bond acceptors.
Where does this data come from?
All data for N-(4-carbazol-9-ylphenyl)-4-[3-[4-(N-(4-carbazol-9-ylphenyl)anilino)phenyl]-5-methylpyrazin-2-yl]-N-phenylaniline;N-[4-(3,6-dimethylcarbazol-9-yl)phenyl]-4-[3-[4-(N-[4-(3,6-dimethylcarbazol-9-yl)phenyl]anilino)phenyl]-5,6-diphenylpyrazin-2-yl]-N-phenylaniline;N-[4-(3,6-diphenylcarbazol-9-yl)phenyl]-4-[3-[4-(N-[4-(3,6-diphenylcarbazol-9-yl)phenyl]anilino)phenyl]pyrazin-2-yl]-N-phenylaniline is sourced from PubChem (CID 157059441), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).